In October 2023, the Orange County Health Care Agency in the USA initiated the “Fentanyl is Forever” media campaign, targeting the urgent challenge of fentanyl misuse. This campaign reflects the agency’s dedication to combating the crisis and its harmful effects on individuals, families, and communities.

Highlighting the severe risks associated with fentanyl misuse, the campaign emphasizes the substance’s potential to destroy lives and relationships. It leverages Opioid Settlement Funds to deliver powerful family narratives, educational content, and information on prevention and intervention, aiming to elevate public consciousness about fentanyl’s lethal risks and promote access to local support services.

A central component of the initiative is an extensive online platform offering a wealth of information on fentanyl’s dangers. This resource hosts educational articles, videos, personal stories, and further resources to guide the public on avoiding or dealing with fentanyl exposure.

The campaign’s reach extends through various media, including digital, broadcast, and social platforms, and is accessible in English, Spanish, and Vietnamese. It involves distributing educational materials across Orange County and engaging the community through social media to spread its critical message.

Launched with a press conference on October 10, 2023, the campaign also introduced the availability of Kloxxado, a potent naloxone formulation, in Orange County, marking a significant step in providing the community with tools to prevent overdoses.

Through ongoing town hall meetings, the campaign educates on fentanyl’s dangers, overdose prevention techniques, and effective response strategies, incorporating naloxone distribution and training.

The “Fentanyl is Forever” campaign signifies a comprehensive effort to tackle the fentanyl crisis, aiming to safeguard lives and foster a well-informed community aware of the substance’s hazards.

For further details, visit www.fentanylisforeveroc.org.

Find more from OCgov.com (USA, October 2023)